Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Juhi Kaveeshvar Patel

Attorney

Juhi Kaveeshvar Patel

Attorney

Washington, D.C.
(202) 827-2960 TEL
(202) 379-3957 FAX
Washington, D.C.
(202) 827-2960 TEL
(202) 379-3957 FAX

Juhi Patel focuses her practice on counseling clients regarding the development and protection of clients' intellectual property assets, with an emphasis on trademark law and brand development and protection. Juhi advises clients across a broad range of industries, including health care, food and beverage, technology, media and entertainment, to develop trademark filing, protection, and enforcement strategies. Prior to joining the firm, Juhi was an examining attorney with the U.S. Patent and Trademark Office (USPTO), where she rendered agency decisions on procedural and statutory issues, as well as successfully defended the agency's position in ex parte appeals to the Trademark Trial and Appeal Board (TTAB).

Juhi's practice involves:

  • Trademark Searching and Clearance – Conducting trademark clearance searches and providing opinions on availability of use and registration of trademarks domestically and internationally.
  • Trademark Filing, Prosecution, and Registration – Registration, maintenance, and renewal of trademarks; prosecuting trademark applications before the USPTO or in foreign jurisdictions with the assistance of local foreign counsel; representing clients in ex parte appeals before the TTAB.
  • Trademark Protection and Enforcement – Monitoring trademarks and domain names for infringement; conducting investigations into infringing use of trademarks and domain names; initiating litigation and non-litigation enforcement efforts when necessary to stop infringement and counterfeiting, including cease and desist letters and inter partes proceedings before the TTAB.
  • Intellectual Property & Technology Transactions – Assisting clients with strategic alliances and transactions involving intellectual property assets, including acquisitions, collaboration agreements, licensing agreements, and assignments.

Memberships

Intellectual Property Owners Association (IPO)

International Trademark Association (INTA)

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Publications

View More

Accolades

Emory Law Journal — Managing Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.